Yan, J., & Bading, H. (2023). The disruption of NMDAR/TRPM4 death signaling with TwinF interface inhibitors: A new pharmacological principle for neuroprotection. Pharmaceuticals, 16(8), . https://doi.org/10.3390/ph16081085
Chicago-Zitierstil (17. Ausg.)Yan, Jing, und Hilmar Bading. "The Disruption of NMDAR/TRPM4 Death Signaling with TwinF Interface Inhibitors: A New Pharmacological Principle for Neuroprotection." Pharmaceuticals 16, no. 8 (2023). https://doi.org/10.3390/ph16081085.
MLA-Zitierstil (9. Ausg.)Yan, Jing, und Hilmar Bading. "The Disruption of NMDAR/TRPM4 Death Signaling with TwinF Interface Inhibitors: A New Pharmacological Principle for Neuroprotection." Pharmaceuticals, vol. 16, no. 8, 2023, https://doi.org/10.3390/ph16081085.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.